ReviewTherapeutics and clinical risk management2020

Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date.

Stephanie Si et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.